BC
Brunswick Corporation
BC has the edge over LCID overall, supported by lower modeled downside and stronger fundamentals.
LCID
Lucid Group, Inc.
LCID offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
BC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Stable |
BC's profitability is currently healthy, and its revenue, cash flow and balance sheet are stable.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
BC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $31.76 | -58% |
| Fair | 14x | $45.28 | -41% |
| Forward | 14x | $76.50 | — |
| Expensive | 21x | $69.06 | -9.7% |
| Current | 23x | $76.50 | — |
Historical ranges are pointers, not guarantees.
BC's PE is in its expensive range at 23x. If earnings grow as analysts expect, today's price would be 14x next year's earnings, in its fair range.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
BC Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BC, with profitability improving.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
BC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.33 | +63% |
| Q3 2026 | $3.27 | +$6.88 |
| Q2 2026 | -$1.27 | -295% |
| Q1 2026 | -$2.06 | -266% |
| Q4 2025 | -$2.08 | -208% |
| Q3 2025 | -$3.61 | -190% |
| Q2 2025 | $0.65 | -87% |
| Q1 2025 | $1.24 | -77% |
| Q4 2024 | $1.93 | -68% |
BC has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
BC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.5B | +6.9% |
| Q2 2026 | $1.6B | +7.7% |
| Q1 2026 | $1.4B | +13% |
| Q4 2025 | $1.3B | +15% |
| Q3 2025 | $1.4B | +6.8% |
| Q2 2025 | $1.4B | +0.2% |
| Q1 2025 | $1.2B | -10% |
| Q4 2024 | $1.2B | -15% |
BC's revenue is recovering but still below its 2022 peak: $1.5B last quarter, up 6.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.2% | +25 points |
| Q2 2026 | 8.3% | +1.2 points |
| Q1 2026 | 3.6% | -1 points |
| Q4 2025 | 3.1% | +8 points |
| Q3 2025 | -18% | -26 points |
| Q2 2025 | 7.1% | -3.8 points |
| Q1 2025 | 4.6% | -3.5 points |
| Q4 2024 | -4.8% | -13 points |
BC has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over BC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
BC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $136.4M | +28% |
| Q2 2026 | $272.4M | +0.4% |
| Q1 2026 | -$121.3M | -$56.2M |
| Q4 2025 | $83.6M | -70% |
| Q3 2025 | $106.5M | +239% |
| Q2 2025 | $271.3M | +66% |
| Q1 2025 | -$65.1M | +$142.3M |
| Q4 2024 | $276.1M | +22% |
BC has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
BC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -400K shares |
| 1 year | -0.9% | -600K shares |
| 3 years | -7% | -4.9M shares |
| 5 years | -17% | -13.2M shares |
| Available history | -24% | -20.5M shares |
BC has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $28.8M |
| Q2 2026 | $15M |
| Q1 2026 | $16.2M |
| Q4 2025 | $15M |
| Q3 2025 | $21.9M |
| Q2 2025 | $17.5M |
| Q1 2025 | $25.6M |
| Q4 2024 | $10M |
BC spent $75M buying back its own shares over the past year, about the same as the year before.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
BC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.8x | Moderate |
| Q2 2026 | 6.5x | High |
| Q1 2026 | 8.1x | High |
| Q4 2025 | 7.3x | High |
| Q3 2025 | 12.2x | High |
| Q2 2025 | 4.0x | Elevated |
| Q1 2025 | 4.0x | High |
| Q4 2024 | 3.5x | Elevated |
BC's net debt is about 2.8 years of its operating earnings (EBITDA), down from 12 years a year ago.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.3 | Neutral |
| Stochastic | 65.3 | Neutral |
BC's weekly RSI is 53 (neutral) and its Stochastic is 65 (neutral).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
BC PE vs Consumer Cyclical Sector
| Metric | BC | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 18x | 30% above |
| PE % | 87 | 47 | 40 pts above |
BC is trading at 23x earnings, a 30% premium to the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
BC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $69.2 | 11% above |
| 20 week MA | $74.2 | 3.1% above |
| 50 week MA | $77.4 | 1.2% below |
| 100 week MA | $68.6 | 11% above |
| 200 week MA | $75.3 | 1.6% above |
BC has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
BC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $60.8 | $81.5 | +34% |
| 2021 | $81.5 | $96.9 | +19% |
| 2022 | $96.9 | $71.4 | -26% |
| 2023 | $71.4 | $96.8 | +35% |
| 2024 | $96.8 | $64.7 | -33% |
| 2025 | $64.7 | $76.1 | +18% |
| 2026 YTD | $76.1 | $76.5 | +0.5% |
BC has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.